Vancouver-based biotechnology company CytoDyn has reached a $12 million settlement with its former research contractor Amarex Clinical Research. Read more… Source: The Columbian
Posts published in “Biotechonology”
Just months after public offering, Absci heading for clinical trials with a biologic drug candidate
By The Citizen on May 14, 2024
After raising nearly $90 million in its recent public offering, Vancouver-based Absci is advancing toward clinical trials for what would be its first biologic drug…